Results 111 to 120 of about 16,313 (146)

Long-term follow-up of neonatal severe hyperparathyroidism: redefining calcium management. [PDF]

Arch Endocrinol Metab
Meira I, Menino J, Ferreira P, Queirós J, Silva D.   +4 more
europepmc   +1 more source

[Impulse control disorder: patients with pituitary adenomas and dopaminergic agonists]. [PDF]

Rev Med Inst Mex Seguro Soc
Barreras-Ruíz A, Rangel-Sánchez MG, Ávalos-Salgado FA, Espinel-Bermúdez MC, Hernández-González SO.   +4 more
europepmc   +1 more source

Beyond insulin-like growth factor-1 (IGF-1) normalization: portal insulin and hepatic growth hormone (GH) sensitivity across metabolic disease. [PDF]

Arch Endocrinol Metab
van AJ, Neggers SJ, Kopchick JJ, Boguszewski CL.   +3 more
europepmc   +1 more source

Tirzepatide and metabolic dysfunction-associated steatotic liver disease (MASLD) in obesity: a real-world multicenter study. [PDF]

Front Endocrinol (Lausanne)
Galasso M, Verde L, Patrone R, Ragozzino G, Annunziata G, Colao A, Barrea L, Muscogiuri G.   +7 more
europepmc   +1 more source

Vitamin B12 replacement strategies: a Brazilian delphi consensus. [PDF]

EClinicalMedicine
Cohen RV, Levinson R, Baiocchi O, Salles JEN, Cavalcante França M, Navarro T, Trujilho F, Soares JM, Nakagawa D, Valente M, Barbuti R, Spera RR, Moura F, Valerio C, Schiavon CA, Dos Santos FC, Batista Dantas AC, Abdo A, Steiner ML, Korkes HA, Cordenonssi JT, Bachour P.   +21 more
europepmc   +1 more source

Tirzepatide as a therapeutic tool for kidney impairment in obesity: insights from a real-world study. [PDF]

J Transl Med
Galasso M, Verde L, Patrone R, Ragozzino G, Annunziata G, Colao A, Barrea L, Muscogiuri G.   +7 more
europepmc   +1 more source

Response to the letter to the editor: Appraisal of suspicious for malignancy cytology: nuclear characteristics deserve special attention in reported cytology analysis - real-world scenario cohort in thyroidology. [PDF]

Arch Endocrinol Metab
Macedo FC, Delfim RLC, Vaisman F.
europepmc   +1 more source